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li INTRODUCTION 
I 
Prior to 1937 cirrhosis of the liver had a hopeless 
prognosis especially after the onaet of ascites. In a few 
cases apparent spontaneous remissions occurred but the 
commonest course by far was that of a relentless progression 
of the disease until death finally put an end to the 
patient's suffering. Once the diagnosis was established not 
much time was spent in attacking the basic pathologic 
process. The usual plan of treatment was concerned mainly 
with making the last months and years of the unfortunate 
victims' life more endurable. Paracentesis,diuresis,a high 
carbohydrate diet snd other palliative therapy were 
employed.(50}. In 1931,Patek (74) evolved his theory of the 
nutritional basis of hepatic cirrhosis,thus offering the 
first intelligent approach to the therapy of this disease. 
Patek (74) undertook a therapeutic trial using a highly 
nutritious diet supplemented by vitamin ~ complex. A 
relatively good result was obtained,thus bearing out Patek's 
hypothesis. These preliminary findings were extended by 
Patek and Post (76) and Patek (72} and various other workers 
shortly thereafter. The majority of patients with hepatic 
cirrhosis soon were being treated by means of a well-defined 
dietary regime supplemented by vitamins and liver extract. 
During this time another group of studies was being 
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conducted on the fatty liver. Infiltration of fat into the 
liver was recognized (22) as one of the antecedent phenomena 
which usher in hepatic cirrhosis and so these experiments 
aroused considerable interest. It was found that diets poor 
in protein and high in fats would produce fatty livers and 
eventually cirrhosis in animals. Diets defecient in certain 
specific agents, lipotropic agents, also resulted in fatty 
livers and cirrhosis. Administration of these lipotropic 
agents prevented the development of the fatty changes in the 
I 
liver. Encouraged by the results of these experiments many I 
clinicians began to employ lipotropic agents, notably choline, ~~ 
in the treatment of human cirrhosis. Here,however, results ,J 
were not as clear cut as in animal experiments. 'rhis is not 
surprising for as Volwiler, Jones, and Mallory \ 91) point out, 1 
"In a chronic disease of unknown etiology, naturally subject I 
to remissions and exacerbations accurate appraisal of 
l1 
therapeutic regimens is extremely difficult." i/ 
It is the purpose of this paper to present the evidenc1 
that has served as the basis for the addition of choline to l 
the dietary management of Laennec's cirrhosis, and to attempt I 
,, 
to evaluate the usefulness. of choline. I 
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CHOLINE 
Choline was first isolated by Strecker in 1849 from 
the bile of pigs (88). However,its role as a dietary factor 
was not suspected for many years. 
In 1924, Allan et al (2), while working with a series 
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of depancreatized dogs for the purpose of measuring the 
glucose equivalent of insulin, noticed that many of the dogs 
died though kept on adequate insulin dosage. ~xtensive fatty 
metamorphosis was found in the liver on post-mortem 
examination. Addition of raw beef pancreas to the diet 
prevented the formation of fatty livers, and it was suggested 
that the effectiveness of raw pancreas might have been due to II 
II its content of digestive enzymes. Several years later,however, II 
'I 
Hershey (44) and then Hershey and Soskin (45) working on the 
I 
I 
I 
hypothesis that the fatty livers might be due to faulty fat 
metabolism rather than a deficiency of pancreatic enzymes, 
showed that crude lecithin could be substituted for the raw 
beef pancreas. In the next year, ~est,Hershey, and Huntsman (9~ 
I 
produced fatty livers in rats and were able to prevent them I 
by feeding purified lecithin• Further research revealed 1
1 
choline as the active principle in lecithin \8,10). I 
I 
Choline then began to occupy a prominent position in j 
medical and biochemical literature as numerous investigations I; 
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were undertaken to determine the exact role of choline in fat 
metabolism. In 1935, casein (llJ was found to exert a 
protective effect similar to that of choline, and later, 
~ucker and Eckstein (90) discovered that the methionine 
present in casein was responsible for its lipotropic action. 
Continued research by other workers (30,31) revealed that a 
reversible reaction existed between choline and methionine, 
such that given methionine, the animal was able to 
synthesize choline; also, choline can act as a donor of 
labile methyl groups in the synthesis of methionine from 
homocystine. 
~ith these studies in mind some men began to suspect 
that diets low in choline or methionine might lead not only 
to fatty livers but to cirrhosis as well. These suspicions 
were soon confirmed by numerous investigators. As a result 
of such evidence the concept of choline therapy was carried 
over to human cases. 
Chemistry 
Chemically, choline is trimethyl beta hydroxy 
ammonium hydroxide. 
The free form is a strongly alkaline, colorless, crystalline, 
extremely hygroscopic compound, readily soluble in water, It 
is a stronger base than ammonia and because of its alkaline 
I 
properties choline easily forms 
chloride was the first salt used 
(77). However, this compound has 
salts with acids. Choline I 
experimentally and clinically II 
an unpleasant taste and 
moreover decomposes readily with the liberation of trimethyl 
amine which itself is distasteful. The chloride salt is often 
irritating to the gastrointestinal tract and may produce 
nausea, vomi tingJ" diarrhea ( 68). Thus,' the more palatable 
choline dihydrogen citrate was introduced, which could be 
bleDded with a syrup resulting in a more acceptable 
preparation for oral therapy. This salt,too, has its draw-
backs,for a high dose (15 gm. daily) is needed to attain the 
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therapeutic response produced by 2 to 3 gm. of choline II 
chloride. Morrison ( 68) advocates the use of choline carbonate II 
which is well tolerated by the patient and is effective at a 
dose of 6 to 8 gm. a day. 
Choline is found in the animal body chiefly in the 
form of the phosphotides - the lecithins and sphingomyelins. 
Lecithin is the glycer'l ester of two fatty acids and a 
substituted phosphoric acid group attached to a choline 
radical. 
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li Lecithin: 
I 
I 
CH-R 
I ~ CH3 
CH-R I 
I ~ ~CH.) 
CH-PO-O•C H-N ~ l ~ .1 ~CH 
OH \ 
3 
OH ) 
Sphingomyelin consists of a fatty acid, sphingosine and a 
choline-phosphoric acid group. 
Sphingomyelin: 
CHOH•CH=CH•(CH~)·CH3 I ... ·~ CH,a 
CHNH-R I 
I ~c~ 
CH~ 0-PI 0-0CH~ CH~~- N 
\' CH3 
OH \ 
OH 
( R represents a fatty acid) 
The foods richest in choline are those containing a 
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I high proportion of phospholipidsi;' Good sources of choline are: I 
egg yolk, beef liver, kidney and muscle, green, leafy and I' 
leguminous vegetables, seed oil meals and grain germs. ~hus it 
is evident that a well rounded nutritious diet will contain 
adequate quantities of choline(l2,33,43,64). 
Lipotropic action 
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When Best and his colleagues disoovored that choline, I' 
betaine and certain proteins could prevent or at least decrease 11 
the rate of deposition, and accelerate the rate of removal of I' 
excess hepatic fat he decided to adopt a name for these agents. 1, 
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II From a large number of suggestions Best chose "lipotropic", II 
I, I' II ,I 
I
I borrowing from the Greek word 11 tropeo", meaning to "affect" or lj 
II 11 change 11 ( 6). The term lipotropic has since been generally ii 
,I i,', 
, accepted and widely used. n 
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It is believed that fats are transported in the blood 
stream chiefly in the form of phospholipids, and that the 
liver is the principle site of formation of these phospholipids~ 
Since the choline-containing lecithin-s and sphingomyelins make · 
I 
up the greater portion of serum phospholipids (1) ·it;,;appears I 
I 
reasonable that the lipotropic action of choline might be due I! il 
to stimulstion of the synthesis of phospholipids, That this is ! 
the case was indicated by several results. The chief effect of I 
choline was in preventing or diminishing the accumulation of I 
glycerides in the liver (7, 60). Mawson and Nelch (63) in 1936 I; 
II 
studying choline, found that the methyl groups were not 
essential for its lipotropic activity but the hydroxyl group 
was. In the same year Welch (95) fed arsenocholine, which is 
lipotropic, to rats and concluded that choline produces its 
lipotropic effect by entering into the formation of 
~I 
II 
I' il 
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I phospholipids. Further work by Welch (93), and later Perlman 
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and Chaikoff (78), confirmed these earlier observations. 
Welch and Landau in 1942 (96) reported that the intact I, 
j 
i 
choline molecule is incorporated into the phosph~ipid molecul,. 
This work received further support by McArthur, Lucas and Ill 
Best in 1947 (59}. 
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Paul, Daum, and Kemp (77) showed that administration !I 
I 
,I 
I of choline resulted in a significant tendency toward 
II 
stabilization of blood lipids toward normal ranges in human [i 
cases of cirrhosis. Cornatzer and Cayer (25) fed choline to 1! 
eight cirrhotic patients (all with large li vera) and found II 
that there was a significant increase in phospholipid turnover i 
when there had been a deficiency of lipotropic agents. 11 
The formation of phospholipids thus appears to be an 
important stage in the metabolism of fats by the liver and a 
stage in which choline is involved. 
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LAENNEC 1 S CIRRHOSIS 
In complete agreement with modern concepts, Moon (65) 
defined cirrhosis of the liver as a progressive chronic 
tion of remaining cells in the direction of regeneration. 
its late stages possessing distinctive characteristics, not 
only anatomically but often also clinically. However, a 
satisfactory classification of hepatic cirrhosis has not yet 
that have been proposed (52,70J. Mallory feels that hepatic 
cirrhosis may be conveniently classified as: 
1. Syphilitic cirrhosis 
(a) congenital 
(b) acquired 
2 • .Healed acute yellow atrophy 
3. tliliary cirrhosis 
4. Pigment cirrhosis 
5. Alcoholic cirrhosis (Laennec's cirrhosis) 
Karsner (52) estimates that Laennec's cirrhosis constitutes 
about half of all cases of hepatic cirrhosis. Others are of 
the same opinion (70,73,80). Hatnoff and Patek (80) reported 
in 1942 that about one third to one half of cases of 
·-------~--
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~-tennec•s lj I cirrhosis are asymptomatic, or latent, and are nEver tl 
I 
i/ 
I' 
II 
II 
,I 
I 
discovered except as incidental findings at autopsy. 
RickettS (82) also points out that the disease is often 
missed because of few or no active symptoms. 'l'hus it is 
evident that the most prevalent form of cirrhosis of the liver I 
I 
I 
I 
is Laennec's cirrho*is. 
Etiology and Pathogenesis 
Although Laennec's cirrhosis has apparently been 
recognized since nearly 300 b.C. (52), its etiology is yet 
obscure. A number of agents can produce a pathological picture I 
similar to Laennec's cirrhosis, e.g., long exposure to I 
I 
arsenic, carbon tetrachloride, cincophen, and others. However, i 
in the great majority of cases no toxic agent can be demonstra~ 
ted. I 
In the United States more than one half of the cases i 
of Laennec 1 s cirrhosis are associated with chronic alcoholism. I 
Present day evidence has ruled out alcohol as the direct I 
cause of hepatic cirrhosis \19,50} but alcohol probably plays 
a contributory role. i·he modern concept appears to indict 
j nutritional deficiency as the etiologic agent. uyBrgy and 
I 
I 
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11 
Goldblatt l40) pointed out that the chronic alcoholic 
frequently subsists on a diet low in protein and containing 
an insufficient supply of the vitamin B complex. ~eri beri, 
pellagra and pmlyneuritis are recognized deficiency diseases 
and are relatively common in chronic alcoholics (84). 
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!1 Therefore, it appears reasonable to suppose that Laennec's II 'I I, 
II 
~I 
I, 
I 
I 
cirrhosis might be the end result of a deficiency of certain 
dietary essentials. Support for this hypothesis can be 
derived from the following: 
1. Many reports of the favorable therapeutic 
response of patients with Laennec's cirrhosis 
to a highly nutritious diet {supplemented by 
vttamins, liver extract and in some cases, 
lipotropic agents)(4,16,32,34,36,66,67,68,71, 
72,74,75,76,85,87). 
2. The prevalence of cirrhosis of the liver in 
certain countries where malnutrition is 
endemic and alcoholism rare \38,99). 
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3. The facility with which hepatic cirrhosis can II 
beproduced in laboratory animals by means of 
1
1 
diets deficient in proteins and lipotropic 
'I 
II agents, and usually high in fat. (13,14,19,~3, I 
I 
I 
24, ~6, 38,41,42, 46,47, 56, 5'1, 58, 81,93 j. 
Davidson and Gabuzda {28) point out that simple undereating 
I 
I 
will not influence the liver; a deficiency of proteins and 
vitamins is needed. 
Animal experiments indicate that the initial result ofl1 
:I nutritional deficiencies is a fatty metamorphosis of the 
hepatic parenchyma eventually progressing to cirrhosis (3,17, il 
18,19,23,38,41,42,46). Needle biopsy studies \5,35,55,83) and II 
pathological observations following autopsy (22,69) +i 
===~.- I === 
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il substantiate the findings in experimental animals. 'l'he fatty !i 
I
I[, changes in the liver are believed to be a combination of fatty II 
~ !I 
: · 1/ infiltration and fatty degeneration {89). However, in the II 
ll d 
11 earliest stages fatty infiltration appears to prsdominate1 with !I 
J a correspondingly high proportion of neutral fat. This is the 1! 
1
1 
lipid upon which choline exerts its greatest influence ( 7). II 
The work of Ashburn,et al (3) suggests that the prolonged II 
'I ~~·I· high fat content of the liver results in injury to the hepatic 
I 
I· 
cells, but the exact mechanism by which this occurs has not as 
I
I 
I 
yet been definitely established. It has been reported that the 
fatty metamorphosis of the liver need not result in cirrhosis 
(38,42), and that cirrhosis can ooour without preceeding fatty 
metamo~phosis (20). However, the bulk of evidence appears to 
indicate that a prolonged dietary deficiency of protein, 
especially animal protein, whether associated with alcoholism 
or not, will result in fatty metamorphosis of the liver which 
in turn will eventually progress to cirrhosis. Whether a 
specific deficiency of lipotropic agents is etiologically 
significant in humans, as in experimental animals, is not. 
known, but such a deficiency probably exsists due to the 
nature of the abnormal diet consumed by most alcoholics. , 
After the liver has been crowded with fat for some timJ 
I 
I the first link in the chain of events leading to the typical 
picture of Laennec's cirrhosis appears to be an infiltration o~ 
the periportal spaces by chronic inflammatory cells. &radually~ 
a fibroblastic transformation takes place in thes• areas. T~" 
1
1 
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fibrous tissue with its capillaries spreads around md through I 
i 
lobules replacing degenerated liver cells and disrupting the il 
normal architectural pattern of the liver. Eventually all that i! 
remain are various sized islands of liver cells, surrounded by 
thick bands of connective tissue containing »ibroblasts, a few 
round cells and many small bile ducts. 
Moschcowitz (69} believes that if during the fatty ! 
I 
stage a proper diet is instituted, the fat gradually decreases II j! 
I 
in amount and the cirrhotic process may then, under favorable 
conditions, cease, resulting in a "latent" cirrhosis. 
I, Pathology 
I· 
I Laennec's cirrhosis has been known under various 
names. Portal cirrhosis, hobnail liver, multilobular cirrhosis, 
chronic interstitial cirrhosis, nodular cirrhosis, gin-drinker• 
liver, atriphic or hypertropic cirrhosis, and alcoholic cirrhos s 
are some of the appellations that have been applied to this 
condition (70,80). 
For the purpose of pathologic description Laennec's 
cirrhosis will be divided into an early and a late stage. 
Early in the course of the disease the liver is 
enlarged or n~rmal in size, soft in consistency and yellowish 
in color. J.he cut surface may have a greasy feel. Histological 
there is a diffuse fatty involvement of the liver cells and a 
compression of the sinusoids. ~he cyloplasm of the cells is 
filled with fat which is generally in the fDrm of large 
I ~ c=~·'= 
droplets, and the nucleus is compressed and displaced to the lj 
I, 
edge of the cell. An increase in perilobular connective tissue I.~~~ 
may be evident. 
I Late in the disease the liver tends to be small and 
shrunken. 'l·he color varies from a drab reddish-yellow to 
brown. ~he liver is firm and nodular, the nodules being 
separated by firm depressions formed by bands of connective 
tissue. 'l'hese nodules are usli.lly light brown in color and 
often have a greenish tinge, while the bands of connective 
tissue are gray. A marked distortion of the normal hepatic 
architecture is a striking microscopic feature of this stage 
of the disease. Groups of liver cells varying in size are 
seen separated by broad bands of connective tissue. 'l'here is 
no true lobular arrangement. Some of the liver cells may show 
a hyaline-like degeneration of their cytoplasm, the so-called 
alcoholic hyaline. The connective tissue strands may contain 
numerous fibroblasts and chronic inflammatory cells, or may 
be relatively acellular. A notable feature of these fibrous 
bands is the presence of a greatly increased number of small 
bile ducts {15,52,61,70). 
Clinical Manifestations 
'!'he signs and symptoms of early cirrhosis are 
generally vague and indistinct for the onset of this disease 
is characteristically insidious. ti1Cketts and Kirsner ~82) 
emphasize the frequency with which the disease cannot be 
II 
I 
I 
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1 recognized in its early stages because of a lack of active 
II clinical symptoms. 
The patient usually has been consuming large quantities! 
of alcohol over a long period and during this time has been i 
I 
I taking meals largely as an afterthought. Weight loss may be 
marked. 'l'he patient's indifference to food may increase and 
there is often nausea and vomiting, especially on awakening in 
the morning. Soon he becomes aware of an increase in the size 
1 of his abdomen. ·.rhis is usually the time when the patient 
first seeks medical aid. Jaundice, bouts of abdominal pain or 
hematemesis may also serve as the presenting symptom in some 
cases. 
I 
In all of these cases the disease has already progress-~ 
ed to the point where signs of hepatic impairment can usually I 
be demonstrated. In addition to ascites the~may be edema, 
particularly of the lower extremities. Generally, the liver, I 
and less frequently the spleen are palpable. There are dilated I 
I 
abdominal and chest veins, spider angiomata, liver palms, and 
hemorrhoids. There may be loss of body hair, disturbances of 
the memenstrual cycle in women and gynecomastia and a 
straight pubic hair line in males. Jaundice is frequent 
especially in the terminal stages of the disease, and is 
often accompanied by severe pruri"U.s. In fatal cases death is 
usually due to hemorrhage~ cholemia or intercurrent infection 
such as bronchopneumonia. 
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The incidence of symptoms and signs, as reported in 
two series of cases, is shown in Table 1. 
Table 1. Symptoms and Signs of Laennec's Cirrhosis 
(per cent Incidence} 
Ratnoff'-Patek * Douglass-Snell # 
386 cases 444 cases 
(1929-1937) (1940-1944) 
Symptoms: 
- ;. abdominal enlargement 39 
a~dominal pain 31 23 
,weight loss 53 22 
fatiJ;tue 4 ~() 
bematemesis 27 16 
unrelated complaints - 1- 14 
no comolaints 
- f 4 
Signs: 
hei?atomegaly 75 71 
ascites 7e 4tj 
,eeripheal edema 61 35 
jaundice 65 ~4 
splenomegaly 44 u32 
collateraT ve1ns 24 19 
* Ratnoff'-Patek (80) 
d Douglass-Snell (29) 
/- not mentioned 
The reduction in incidence of signs and symptoms sue 
as weight loss, ascites, jaundice, etc. betweGn these two 
series of cases may reflect the influence of earlier diagnos 
and a more intelligent treatment of this disease in the late 
series. 
Liver function tests such as thetbromsulfalein and 
cephalin flocculation tests will usually indicate hepatic 
damage. Serum bilirubin is often increased, and serum 
cholesterol esters are usually reduced. Characteristically, 
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there is an altered albumin-globulin ratio. Post and Patek l79 >11 
feel that there is a correlation between the clinical course il 
II 
II 
and serum albumin levels, clinical improvement being 
associated with a rise in serum albumin toward normal. I 
Measurements of hepatic function,however, may sometimes be 
misleading and there has been a tendency in recent years to II 
!I 
1 
supplement these laboratory proceedures with needle biopsy I' 
studies. liiopsies have been extremely helpful in the diagnosis 1l 
II 
j! 
,I 
II 
of cirrhosis and in the evaluation of the progress of the 
disease. However, Ricketts,et al (83) feel that biopsies 
I 
cannot replace liver function tests as an indication of the /I 
II I severity of hepatic failure. As a result of their studies I 
l1 Ricketts and his associates ( 83) concluded that there is no 
1
11 
II good correlation between the eegree of hepatic insufficiency II 
and the degree of fibrosis or parenchymatous changes. For, ~~ 
they point out, a biopsy indicates the picture in only a small!: 
locus while liver function tests show function of the organ as II 
II 
II a whole. 
The prognosis of Laennec's cirrhosis although considert 
ably improved over the last two decades is still far from ~~ 
satisfactory. Douglass and Snell ( 29) in their study of 444 I: 
:I 
\, 
it 
cases found that only slightly more than half (57.5%) of the 
II 
I' 
II 
patients followed survived for one year after the diagnosis 
was made; and less than half (48.9%) survived as long as two 
years. Patek (75) attributes the rather poor diagnosis in 
i 
I 
l 
this disease chiefly to the fact that the cirrhotic process 
17 
il 
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~ usually far advanced before therapeutic proceedures are 
I :::::::::d:sT::.:·::v:::s:arly diagnosis of Laennec's 
18 
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EXPERIMENTAL DIETARY CffiHHOSIS AND 'J'HE LIPOTROPIC FACTORS 
Soon after Patek (74) introduced his concept of the 
nutritional basis of Laennec 1 s cirrhosis experimental work in 
this field markedly increased. Chaikoff, Connor, and biskind 
(18) maintaining depancreatized dogs on insulin and a lean 
diet supplemented with vitamins,reported that fatty livers 
developed in about sixteen weeks, and typical portal cirrhosis 
in about a year and a half. This was perhaps the first 
experimental evidence that the prolonged presence of fat in the 
liver gave rise to cirrhosis. In the same year (1938), 
II 
r 
,I 19 
I 
Chaikoff and Connor l23) produced hepatic cirrhosis in normal 
::::h::.~;n:i::e::e::i:::: :: :::a:::.·;::~:::::::dw::;inite ~~ 
dirrhosis, moderate in degree but in all ways resembling that II 
found in man." Later, in 1940 (17) similar lesions were 
produced by high fat diets alone. In all of;; these experiments 
an accumulation of fat in the liver preceeded the development 
of cirrhosis. Hich and Hamilton (81} in 194~feeding diets 
deficient in proteins and various vitamins, and later diets 
adequate in protein, but lacking yeast, were able to produce 
cirrhosis of the liver in rabbits. The main feature of the 
lesions was scarring; necrotic cells were rare. 'l'he authors 
concluded that the scarring was not the result of repair of 
foci of necrosis. In 1939, uy6rgy and etoldblatt {39) reported 
that rats kept on a diet deficient in pyridoxine but 
ii 
II 
I 
containing riboflavin and thiamine developed hepatic lesions 
consisting of fatty degeneration, necrosis and sometimes 
hemorrhage. 'l:hese changes were prevent~ by yeast. 
Channon, et al l21) in 1940 reported that addition of 
cystine to a high fat, low protein diet greatly increased fat 
i 
deposition in the livers of rats. Choline was found to antidotal 
this effect of cystine. Webster \93) produced necrosis and 11 
I 
cirrhosis of the liver in rats, by means of diets low in 
::::::: ::d.:::::::r::dt:i::0 i:i::t~.::l::;n:nt::ti:::::::ni:f I! 
the severity of the f!ibrotic changes in the liver. Yeast did II 
not prevent these lesions but, increasing the protein, or 
1 decreasing fat or addition of molasses, did. 
Blumberg and urady {13J readily produced cirrhosis in 
rats with a high fat, low protein diet. ~hey described the 
hepatic changes as progressing through three stages. The 
initial stage was one of fatty changes in which most of the 
parenchymal cells became filled with fat. This picture then 
I 
I 
I 
I 
1l 
I 
I 
progressed to the stage of fatty changes with minimal cirrhosi I· 
There was a proliferation of connective tissue, especially in II 
the portal and perilobular areas. The final stage was that of lj 
a diffuse nodular cirrhosis in which only scattered nodules of I hepatic cells remained surrounded by extensive fibrous tissue ·II 
Chaitoff,et al,{l9) in an extensiO- of his earlier lj 
work again demonstrated the production of cirrhosis in normal I 
20 
dogs by means of diets low in protein and high in fat. He + 
·= ~~-= 
I 
I 
II 
repeated his earlier observations that the accumulation of 
11 
!) fat in the liver is an important causative agent in cirrhosis. I 
I' I 
1
1 During this time, Lillie,Daft and Sebrell {26,27,57} produced 
necrosis and cirrhosis in rats by die:tary means. 'l'hese men ~~~ 
I! 
felt that necrosis and cirrhosis were separate and distinct 
entities. 
In 1944, Himsworth and Glynn (46) supported ths views 
I' ,I 
'I I, 
Ill 
, of Lillie ,Daft, and Sebrell that necrosis and cirrhosis of 11 
I
I ,'1,,1 the liver produced by dietary means were distinct lesions. 
1
1 
Hepatic necrosis was felt to result from a deficiency of II 
II 
certlfin amino acids. This lesion appeared suddenly in an !1 
I apparently heUthy animal, was not proceeded by fatty changes, II 
was not preventable by choline, and pathologically resembled jl, 
acute yellow atrophy in man. Healing of the lesions gave a II 
II 
II 
I 
I 
picture similar to that of healed acute yellow atrophy in 
humans. On the other hand, cirrhosis was due to a deficiency 
of lipotropic factors, was preceeded by a prolonged fatty 
infiltration factors, and was preventable by choline. This 
II 
I Glynn (46) believed that only four previous groups of workers 1 
had succeeded in producing a true cirrhosis by dietary means; II 
II 
II 
lesion developed slowly over a long period of time and 
pathologically resembled Laennec's cirrhosis. Himsworth and 
Chaikoff, et al (19), Rich and Hamilton (81), Blumberg and 
Grady (13) and Webster (93). A high fat diet was employed in 
all of these experiments. 
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and other lipotropic agents on these hepatic lesions is now in !1 
order • .blumberg and McCollum {14) produced cirrhosis in rats I 
with a high fat, low protein diet specifically low in choline. ! 
II 
Cirrhosis developed to a marked degree within 100 to 140 days. 
Cystine (25 mg. daily) had no effect on the cirrhosis. 
Methionine (25 mg. daily) retarded the process, while choline 
(40 to 60 mg. daily), alone or in combination with either 
cystine or methionine prevented it. Daft,Sebrell, and Lillie 
(26) produced cirrhosis in rats on a low prot€in,low fat diet. 
Choline, methionine and casein, alone or in combination 
I 
I 
I 
I, 
I 
I 
prevented formation of the lesion. Alcohol {57) was thought to \1 
II 
II 
II 
have apparently aggravated the hepatic changes. Lowry,et al, 
(58) demonstrated that although lipotropic agents prevented 
further progression of an already existing cirrhosis and II 
I :::u~:::o:: :1::::1::: :::0::~.::.:~·::: :::r::::P::·f::::::. ~~ 
il were described in a subsequent paper {56). It was felt that 
the experimentally produced cirrhosis differed from that 
occuring in humans because of the presence in the former of 
small droplets of an acid fast, golden yellow pigment, which 
was named ceroid. 
In 1942, Gy8rgy and Goldblatt (40) showed that both 
cystine and choline are necessary for the prevention of 
dietary necrosis and cirrhosis in rats. iJ:•hese men felt that 
other workers who had claimed complete prevention of both 
lesions by choline alone, had fed the animals a diet 
I' ,I 
li 
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il 
containing cystine ~en if only in small quantities. 'l'his work il 
I, 
received further support in the same year when Daft,Sebrell, li 
and Lillie (27) reported that choline alone prevented the 11 
development of dietary cirrhosis in rats, but not necrosis, I 
and cystine alone prevented only necrosis, while methionine 
prevented both. 
Himsworth and Glynn in 1944 (47) using protein 
deficient diets produced hepatic necrosis in rats and found 
that this lesion was prevented only by methionine or casein, 
but not by cystine alone or cystine and choline in 
combination. However, when cirrhosis (46) was produced by f 
feeding diets poor in lipotropic factors, cholime alone or 
yeast could prevent the lesion from developing. In 1948 
Sellers,Lucas and Best (86} reported that addition of either 
choline or methionine to the diets of rats in which a 
I 
I 
• 
I 
i 
I 
II 
moderate degree of cirrhosis had been produced by carbon 1 
tetrachloride, resulted in a marked improvement of the hepatic 1
1 
picture, both grossly and histologically. '!'hey stressed the r 
point that some of the experimental results that have been 
reported in the li•erature are difficult to evaluate because 
the basal diets employed eontained significant quantities of 
lipotropic agents. In this same year, Gy6rgy and Goldblatt (41) 
again working with rats were able to produce cirrhosis and 
necrosis at will by diets deficient in lipotropic factors and 
high in fat. Choline prevented the development of cirrhosis, 
but appeared to enhance necrosis. Cystine although it enhanced I 
the cirrhotic process, was necessary to protect the liver 
against necrosis. In 1950, Jaffe,~issler, and Benditt (49) 
II 
II II 
II 
+ !j 
'I 
!, 
i, 
1: ,, 
produced cirrhosis in rats by means of diets high in fat and II 
I' II low in protein and lipotropic •~ators. After cirrhosis had 
been established lipotropic agents were added to the diet. 
Methionine and choline each were found to have a ~eneficial 
effect on the cirrhosis, while cystine alone or various 
combinations of the three substances produced no effect. 
'ihus it appears that cystine in some way hinders the 
lipotropic action of choline and methionine in cirrhosis. 
"£he relationship of cystine to choline and the other 
lipotropic factors needs further clarification. However, it 
is obvious that the studies of many workers.have firmly 
II 
II 
I 
II 
I 
'! 
I 
I 
established that the lipotropic factors are intimately j 
concerned with dietary cirrhosis in expermimaatal animsls, a~ 
that accumulation of fat in the liver preceedes the develop- 11 
ment of cirrhosis. •rhe significance of this typeof cirrhosis ![ 
in relation to that in humans is not entirely clear. However, 11 
as Davidson and ..:tabuzda ( 28) point out, '''!'he evidence incrimilll 
nating dietary factors in the pathogenesis of liver dise·ase II 
in animal experiments is necessarily more specific than that I· 
r 
in man, but the two bodies of evidence are compatible." II 
Gillman,et al (38) have presented perhaps the most stimulatin, 
evidence that human and experimental cirrhosis might be relat1r· 
'ihis group of workers noted the high incidence of cirrhosis ' 
in certain North African natives who lived on a diet 
24 
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11 I consisting lllllinly of "mealie-pap" and sour milk. ttats placed 11 
I 
I 
I 
I 
on such a diet developed severe 11 ver damage, some of the l1 
I' 
lesions resembling cirrhosis. il 
II 
II 
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DIETARY MANAGEMENT OF LAENNEC'S CIRRHOSIS 
Nutritious Diet 
Patek ( 74) first demonstrated that a highly nutritious~~ 
diet would prOduce a favorable effect in cirrhotic patients. I 
His work was soon confirmed by Patek and Post (76}, Fleming 
and Snell (34), Hoagland (48) and in subsequent years by many 
others. 'l'his concept has also received support from the many 
experimental studies in animals mentioned previously. 'J:-he 
dietary management of Laennec's cirrhosis resulted from a 
logical approach to the problem and offers new hope to 
patients who in previous )ears were almost certainly doomed tol I 
an early death. 
i 
'lhe dietary regime in Laennec's cirrhosis is designed II 
to correct the factors that predispose to the disease, and to j[ 
establish optimal conditions 'under which remaining vital liver 
tissue may be regenerated. Accordingly, the basic features of 1 
this dietary regime have generally included the following 
measures: (29,6'1,'15,77) 
1. elimination of alcohol from the diet 
2. a reduction in fat intake 
~. ingestion of large amounts of carbohydrate 
and protein 
4. supplements of vitamins and liver extract 
26 
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il 
The elimination of alcohol has always been a standard I[ 
proceedure in the management of cirrhotic patients, for the 11 
frequent association of alcoholism with cirrhosis has long !I 
11 
been known. It is recognized that alcohol in itself its not I 
directly. responsible ~or the development of cirrhosis, Yet its I 
l 
complete elimination from the diet of these patients is 11 
probably justified despite th€ observations of Volwiler, Jonesj 
and Mallory (91) that a moderate alcohol intake will not 
interfere with the repair of liver damage 1~ diet is adequate. II 
A low fat diet has been advocated on the basis of 11 
animal experiments in which high fat diets were shown to in- [! 
crease liver injury. However, Patek (71) maintains that there I 
is insufficient evidence to warrent severe fat restriction in 
this disease. Davidson and Gabuzda (28) likewise feel that 
adequate amounts of fat comprise an essential part of a 
nutritious diet and should be restricted only when severe il 
biliary obstruction exists. I 
patients with cirrhosis usually exhibit tissue I 
wasting and a low level of serum proteins. Thus a high dtetaryl 
lave 1 of protein is administered in an attempt to restore the II 
prot a in stores of the body. A high intake of carbohydrate is 1
1 
employed to provide the caloric needs of the body and thus 
help spare protein. Practically all clinicians adhere to 
these principles. 
Supplements of Vitamin B complex were first used by 
Patek (74,76) on the basis of observations by fiomano (84) and 
--·-=jj=================== 
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!J have since, along with other vitamins and liver extract, been J 
~~ prescribed routinely by most clinicians. A history of long li 
I term vitamin deficient diets is common in most cases of Jl 
J cirrhosis, and so it is felt that high levels of vitamins I 
I
I will aid in maintaining optimal conditions for recovery. 1t 1 
I 
I 
is also hoped that thiamine will combat the anorexia that so 
frequently accompanies cirrhosis. '!'he use of vitamin aupple- II I· 
ments is largely empirical, and may not actually be necessary.! 
However, as long as even a possibility exists that addition ofl 
vitamins and 11 ver extract might be of value, and since there II 
is no evidence that in the doses used they will produce any I 
J, 
" II 
II 
I 
untoward effects they should be employed, particularly in 
those cases where anorexia materially interferes with food 
intake. 
A moderately low intake of sodium has also been 
advocated, as being helpful in the control of ascites {52). 
I 
Lipotropic agents li li 
As a result of the pathological, chemical and nutri- I' 
tional data accumulated from animal experiments demonstrating~ 
thB re&ationship of lipotropic factors to cirrhosis it was 1 
inevitable that the value of these agents as supplements to II 
a nutritious diet would be investigated in hUman cases of 
cirrhosis. The first clinical report on the use of choline 
was probably that of ~roun and Muether {16) in 1942 who 
added one gram of choline chloride a day to a dietary regime 
consisting of high protein, low fas, and vitamins A,D, and thel 
B complex. These men commented that addition of choline was of 
definite value. Yater (98) in 1943 also reported more favor-
able re.-Ats when choline was added to the diet. Other reports 
of the successful therapeutic use of choline soon followed. 
Russakoff and Blumberg t85) in 1944 observed that cholin• was 
of special value in tn early stages of cirrhosis when the 
liver is enlarged and fatty. Morrison (66) in lg46, placed 
19 cirrhotic patients on a nutritious diet supplemented with 
vitamin B complex and liver extract. Anothergroup of 20 
patients reveived the same dietary regime with the addition of 
choline and methiomine \2 gms. of each daily). A marked reduc-
tion in mortality, morbidity and disability rate was noted in !1 
the group receiving the choline and rrsthionine. In the s~ I' 
I 
year, BeamB··~rted similar results with the use of choline and 
cystine (1.5 to 3 gm. of each daily) in cirrhotic patients 
with enlarged livers. He suggested that lipotropic agents 
I 
might be of special value in patients who were not able to II 
toJlerate much food. '!'he following year, beams and J:!;ndicott (5) I 
studied the histological effect of methionine in a series of 
9 patients with Laennec's cirrhosis, and concluded that 
methionine was responsible for the favorable results that 
~ were produced. 
'• Franklin and his colleagues (35) used needle biopsies 
and found that administration of lipotropic substances 
resulted in a withdrwwal of fat from the liver and an arrest 
29 
I 
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II 
+ of the progress of the cirrhosis, but the ~ibrous tissue 
I 
already formed was not effected. Morrison (67,68), Steigman l8l) 
Paul,Daum and Kemp (77} and others (36,97) all substantiated 
the claims of earlier workers that lipotropic agents produced 
beneficial effects over and above that of a nutritious diet. 
one important fact stood out in all of these studied -
the earlier in the course of the disease that treatment was 
begun, the better were the results. Lipotropic agents are able 
to produce a reduction in liver fat and inhibit progress of the 
disease, but, if marked fibrosis had already occur•ed, then 
neither lipotropic agents nor any other substances now known 
are able to reverse the pepatic picture. 
However, studies of the effectiveness of lipotropic 
agents were not all in agreement. Patek {71,73) tested the 
effects of choline and methionine in 8 patients who were in a 
"state of constant progressive liver failure,"and concluded 
that these agents produced DD added beneficial response. Man, 
I 
II 
,I 
I 
et al {62J likewise, in their small series of cases, could not / 
find any evidence that lipotropic agents were of value. 
I 
Volwiler, Jones, and Mallory (91) felt that addition of lipo-
tropic factors to an adequate food diet was unnecessary, but 
admitted that evaluation of the effectiveness of these 
n substances was extremely difficult. 'l'hey suggested adoption of 
a threefold criterion - clinical improvement, a change toward 
normal in liver function tests, and repair of the liver as 
seen histologically by means of serial liver biopsies. 
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that 11 Seife, and Lisa (55} using such criteri~A found 
in a series of 8 cases addition of choline offered no 
1[ 
I
ll advantage• over proper diet alone. 
and balfour ,32) 1 Douglass and Snell (29), Davidson and 
I 
Wade, et al ~92), ~usterman: 
I 
I 
II 
Gabuzda (28) and uabuzda, et al (37J held similar opinions. 
Most of these workers felt that claims of the effectiveness 
of lipotropic agents were premature. J.he series of cases were 
too small, and the difference in results between controls and 
test groups not significant. FUrthermore, highly nutritious 
diets in themselves contain adequate amonnts of lipotropic 
factors so that additional amounts are not necessarv. I ~ I 
However it can be point~ out that failure of lipotropi~ 
agents to produce beneficial effects in some studies, I/ 
particularly those of Patek (71,73} was undoubtably due to the I 
fact that these substances were administered too late. In 
these cases the livers were already mibrosed to a marked 
degree. Moreover, the series of cases in which lipotropic 
I 
agents were of no avail were also small. 'l'he observations that lj 
the therapeutic diets employed in c-.rrhosis provide adequate 11 
amounts of lipotropic factors cannot be denied. However, it isl 
well known that anorexia is a frequent concomitant feature of I 
Laennec's cirrhosis and is often so severe that the patient II 
'I cannot ingest a sizeable portion of his diet. It appears that II 
in such cases, lipotropic agents should be o~ some benefit. 1 
The need for further study is clear. I 
II 
,, 
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I 
SUMMARY AND GONCLUSIONS 
Nutritional deficiency is now believed to be at 
least one of the etiologic factors in the development of 
Laennec's cirrhosis. Support for this concept can be derived 
from animal experiments, the prevalence of cirrhosis in 
countries where malnutrition is endemic, and the response of 
patients to dietary therapy. The diet of these patients appears! 
to have been particularly low in meat and dairy products. A 1 
deficiency of lipotropic factors has not been specifically 
indicted in humans as in animals, however, diets low in 
animal proteins are likely to be poor in lipotropic factors. 
The first step in the development of Laennec's 
, cirrhosis is an accumulation of fat in the liver. '!'his has l 
been demonstrated in both animals and humans. With time fibrosi 
occurs and as ta cirrhotic process continues parenchymal cells 
degenerate and the liver becomes smaller and contains less fat. 
Animal experiments have indicated that resumption of a normal 
diet must be instituted before fibrosis has become marked if a 
in a dramatic reversal of the cirrhotic process if treatment 
after advanced cirrhosis has been established then further 
32 
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I prouession of the disease is inhibited, but the fibrous tissuil 
j! already formed is unaffected. 'l'hese results have been reprodu-ll 
ced by many experimenters. . 
Dietary management of Laennec's cirrhosis is now well , 
established but the effectiveness of lipotropic agents is I' 
I! still a debatable point. Numerous clinicians have reported I :·::::::::u:e::::·::o::~ O::::e ;::::s o;v::r:::.:::v: ::::l:f I, 
of their clinical trials have come to the conclusion that the I 
use of lipotropic factors is unnecessary. ~he arguments that 
have been employed by each sChool of thought against the 
claims of the other, in my estimation, can be well directed at 
both. More work and a larger series of cases is needed before 
the question of the effectiveness of lipotropic agents can be 
answered. 
Persons suffering from Laennec 1 s cirrhosis are anti tle, I 
to every possible aid, for although considerable advances hav~ 
been made in the therapy of this disease over the past decade ,ji 
the prognosis is still relatively poor. It has not been 
1
11 
proven beyond doubt that choline (and the oth<r lipotropic 
1
1 
.I 
aulrstal)ce s) is not of value as an adjuvant to dietary therapy ll 
Choline, particularly in the form of its carbonate salt, 11 
produces no ill effects in the body, and so it can and should I 
be used routinsly. rt must be emphasized again that treatment~~ 
should be instituted as early as possible in the course of 
the disease while the liver is still enlarged and fatty and I 
==* 
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before much fibrosis has occurred. Choline may prove to be of~ 
special benefit in those cases in which anorexia is pre sent I 
and severe enough to seriously hamper food intake • :1 
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